title: Pathological classification and molecular genetics of meningiomas.
abstract: Meningiomas are extremely common adult brain tumors originating from meningeal coverings of the brain and spinal cord. While most are slowly growing Word Health organization (WHO) grade I tumors, rare variants (clear cell, chordoid, papillary, and rhabdoid), as well as brain invasive (WHO grade II), atypical (WHO grade II), and anaplastic (WHO grade III) meningiomas are considerably more aggressive. This review summarizes the histopathological and genetic features of meningiomas, including differential diagnosis, pitfalls, and grading challenges. Early stages of meningioma tumorigenesis are closely linked to inactivation of one or more members of the 4.1 superfamily, including the neurofibromatosis type 2 (NF2) and 4.1B (DAL-1) genes, which interact with the 14-3-3 protein family. Other chromosome 22q genes implicated include BAM22, BCR (breakpoint cluster region), and TIMP-1, the last of which is implicated in higher-grade meningiomas. Atypical meningiomas also commonly show chromosomal losses of 1p, 6q, 10, 14q, and 18q, as well as multiple chromosomal gains. While most relevant genes remain unknown, two chromosome 14q candidates (MEG3 and NDRG2) have recently been identified. In addition to alterations of CDKN2A, p14(ARF), and CDKN2B tumor suppressor genes on 9p21, a contribution of the wingless (wnt) pathway with alterations of the E-cadherin and beta-catenin proteins, as well as alterations of the hedgehog signaling pathway have been implicated in anaplastic meningiomas. The integration of histopathological appearance, complex genetic/genomic data, and outcome will likely result in the identification of clinically distinct meningioma subgroups, which in turn can facilitate the development of targeted therapeutic strategies.
authors.affiliation: Department of Neuropathology, Otto-von-Guericke-University Magdeburg, Leipziger Strasse 44, Magdeburg, Germany. christian.mawrin@med.ovgu.de
authors.forename: Christian
authors.initials: C
authors.lastname: Mawrin
authors.forename: Arie
authors.initials: A
authors.lastname: Perry
mesh_terms: D006801:Humans; D008577:Meningeal Neoplasms / Q000145:classification* / Q000235:genetics* / Q000473:pathology; D008579:Meningioma / Q000145:classification* / Q000235:genetics* / Q000473:pathology; D008967:Molecular Biology
references.citation: Brain Pathol. 2006 Jan;16(1):15-9
references.pmid: 16612978
references.citation: PLoS One. 2010 Jun 21;5(6):e11231
references.pmid: 20574529
references.citation: Br J Neurosurg. 2007 Dec;21(6):588-92
references.pmid: 18071986
references.citation: Brain Pathol. 2005 Apr;15(2):109-15
references.pmid: 15912882
references.citation: Am J Clin Pathol. 2001 Feb;115(2):213-8
references.pmid: 11211609
references.citation: Nat Med. 1998 Aug;4(8):915-22
references.pmid: 9701243
references.citation: J Neurosurg. 1994 Sep;81(3):466-71
references.pmid: 8057157
references.citation: Cancer Genet Cytogenet. 2005 Oct 15;162(2):135-9
references.pmid: 16213361
references.citation: Cancer Res. 1997 Jun 15;57(12):2369-72
references.pmid: 9192811
references.citation: Histol Histopathol. 2010 Mar;25(3):341-9
references.pmid: 20054806
references.citation: J Neurooncol. 2009 Dec;95(3):367-375
references.pmid: 19562258
references.citation: Mol Med. 2010 Jul-Aug;16(7-8):262-70
references.pmid: 20386868
references.citation: Brain Pathol. 2010 May;20(3):623-31
references.pmid: 19922547
references.citation: J Neurosurg Sci. 2003 Sep;47(3):167-71; discussion 171
references.pmid: 14618130
references.citation: Int J Cancer. 2003 Feb 10;103(4):483-8
references.pmid: 12478663
references.citation: Ann Neurol. 2004 Aug;56(2):295-8
references.pmid: 15293284
references.citation: Clin Neuropathol. 2001 Sep-Oct;20(5):190-5
references.pmid: 11594503
references.citation: J Neurooncol. 2008 Mar;87(1):63-70
references.pmid: 18066497
references.citation: Minim Invasive Neurosurg. 2009 Oct;52(5-6):216-21
references.pmid: 20077361
references.citation: Virchows Arch. 1998 Feb;432(2):163-7
references.pmid: 9504862
references.citation: Int J Cancer. 2005 Mar 20;114(2):249-56
references.pmid: 15540215
references.citation: J Neurosurg. 1991 Jan;74(1):129-32
references.pmid: 1984492
references.citation: Hum Mol Genet. 2000 Jun 12;9(10):1495-500
references.pmid: 10888600
references.citation: J Clin Oncol. 2008 Oct 1;26(28):4688-90
references.pmid: 18824717
references.citation: Am J Pathol. 2001 Aug;159(2):661-9
references.pmid: 11485924
references.citation: J Neurosurg. 2004 Aug;101(2):210-8
references.pmid: 15309910
references.citation: Clin Neuropathol. 1995 Nov-Dec;14(6):327-30
references.pmid: 8605738
references.citation: Hum Mol Genet. 1994 Aug;3(8):1393-9
references.pmid: 7987321
references.citation: Am J Surg Pathol. 2004 Nov;28(11):1532-6
references.pmid: 15489659
references.citation: Mol Cell Biol. 2009 Nov;29(21):5923-40
references.pmid: 19703993
references.citation: Cancer Genet Cytogenet. 2010 Jan 1;196(1):1-6
references.pmid: 19963129
references.citation: Neurosurgery. 2008 Oct;63(4):771-80; discussion 780-1
references.pmid: 18981889
references.citation: J Neurooncol. 2008 Mar;87(1):43-50
references.pmid: 18060363
references.citation: Am J Surg Pathol. 1997 Dec;21(12):1455-65
references.pmid: 9414189
references.citation: Brain Pathol. 2010 Jul;20(4):751-62
references.pmid: 20015288
references.citation: Cancer Genet Cytogenet. 2008 May;183(1):14-20
references.pmid: 18474292
references.citation: Cancer. 1999 May 1;85(9):2046-56
references.pmid: 10223247
references.citation: Cancer Res. 2010 Mar 15;70(6):2350-8
references.pmid: 20179190
references.citation: Hum Pathol. 1998 Feb;29(2):140-5
references.pmid: 9490273
references.citation: Int J Oncol. 2010 Apr;36(4):983-90
references.pmid: 20198344
references.citation: Cancer Genet Cytogenet. 2008 Jul 15;184(2):87-93
references.pmid: 18617056
references.citation: Neurosurgery. 2009 Jan;64(1):56-60; discussion 60
references.pmid: 19145156
references.citation: Surg Neurol. 1986 Nov;26(5):461-9
references.pmid: 3764651
references.citation: Cancer Sci. 2009 Dec;100(12):2235-41
references.pmid: 19737147
references.citation: Cancer. 2001 Aug 1;92(3):701-11
references.pmid: 11505418
references.citation: Pathology. 2009;41(7):649-54
references.pmid: 19672786
references.citation: Cancer Invest. 2006 Dec;24(8):727-33
references.pmid: 17162554
references.citation: Cancer Genet Cytogenet. 2007 Apr 1;174(1):48-53
references.pmid: 17350466
references.citation: Mod Pathol. 2004 Jun;17(6):705-10
references.pmid: 15073599
references.citation: J Neuropathol Exp Neurol. 2004 Oct;63(10):1015-27
references.pmid: 15535129
references.citation: Am J Surg Pathol. 2000 Jul;24(7):899-905
references.pmid: 10895812
references.citation: Mol Cell Biol. 2005 Nov;25(22):10052-9
references.pmid: 16260618
references.citation: Cancer Res. 2005 Aug 15;65(16):7121-6
references.pmid: 16103061
references.citation: Brain Pathol. 2002 Apr;12(2):183-90
references.pmid: 11958372
references.citation: Clin Neuropathol. 2009 Nov-Dec;28(6):453-9
references.pmid: 19919820
references.citation: Neurology. 2010 Apr 27;74(17):1396
references.pmid: 20421586
references.citation: Oncogene. 2004 Apr 29;23(20):3589-96
references.pmid: 15116094
references.citation: J Pathol. 2006 Mar;208(4):564-73
references.pmid: 16353169
references.citation: Cancer. 1998 Jun 1;82(11):2262-9
references.pmid: 9610708
references.citation: Cancer Res. 2005 Apr 1;65(7):2653-61
references.pmid: 15805262
references.citation: J Pathol. 2001 Jul;194(3):367-72
references.pmid: 11439370
references.citation: Mol Cancer. 2007 Oct 15;6:64
references.pmid: 17937814
references.citation: Orphanet J Rare Dis. 2006 Oct 02;1:38
references.pmid: 17014705
references.citation: Brain Tumor Pathol. 2009;26(2):51-7
references.pmid: 19856215
references.citation: Int J Cancer. 2001 Oct 15;94(2):218-21
references.pmid: 11668501
references.citation: Genes Chromosomes Cancer. 2005 Mar;42(3):314-9
references.pmid: 15609345
references.citation: J Neurooncol. 2010 Aug;99(1):41-8
references.pmid: 20094774
references.citation: Cancer. 1988 Jul 15;62(2):391-406
references.pmid: 3383139
references.citation: Virchows Arch. 2010 Apr;456(4):343-54
references.pmid: 20165866
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24
references.pmid: 9405679
references.citation: J Cancer Res Clin Oncol. 2010 May;136(5):695-702
references.pmid: 19908067
references.citation: Brain Res. 2010 Jun 8;1336:98-102
references.pmid: 20388496
references.citation: N Engl J Med. 2007 Nov 1;357(18):1821-8
references.pmid: 17978290
references.citation: J Neurooncol. 2010 Dec;100(3):465-73
references.pmid: 20454999
references.citation: Am J Pathol. 1995 Apr;146(4):827-32
references.pmid: 7717450
references.citation: Brain Pathol. 2004 Oct;14(4):457-9
references.pmid: 15605995
references.citation: J Neurosurg. 1997 May;86(5):853-8
references.pmid: 9126902
references.citation: Brain Tumor Pathol. 2009;26(2):69-72
references.pmid: 19856217
references.citation: Am J Surg Pathol. 2001 Apr;25(4):472-8
references.pmid: 11257621
references.citation: J Neurosurg. 1986 Jan;64(1):58-63
references.pmid: 3941351
references.citation: J Neuropathol Exp Neurol. 1995 Sep;54(5):698-703
references.pmid: 7666059
references.citation: Hum Pathol. 2010 Feb;41(2):199-207
references.pmid: 19801161
references.citation: Surg Neurol. 1987 Apr;27(4):319-22
references.pmid: 3824137
references.citation: Cancer Genet Cytogenet. 2005 Oct 1;162(1):63-7
references.pmid: 16157202
references.citation: J Clin Neurosci. 2010 Feb;17(2):253-5
references.pmid: 20036547
references.citation: J Neuropathol Exp Neurol. 2009 Oct;68(10):1155-65
references.pmid: 19918127
references.citation: Nat Genet. 1994 Feb;6(2):180-4
references.pmid: 8162072
references.citation: Hum Pathol. 2005 Apr;36(4):416-25
references.pmid: 15892004
references.citation: BMC Genomics. 2007 Jan 12;8:16
references.pmid: 17222329
references.citation: Am J Surg Pathol. 1998 Dec;22(12):1482-90
references.pmid: 9850174